{'fraction_non_alphanumeric': 0.035056446821152706, 'fraction_numerical': 0.0344622697563874, 'mean_word_length': 4.557755775577558, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
PLACE OF MAGNESIUM OROTATE IN THE COMPLEX THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH HYPERURICEMIA

One of the actual problems of management of patients with type 2 diabetes in combination with HUE is the choice of optimal complex drug therapy. The aim of the study was to evaluate the effectiveness of magnesium orotate in combination with standard hypoglycemic therapy in patients with type 2 diabetes with HUE. 161 patients with type 2 diabetes were examined (67 men and 94 women) who received oral hypoglycemic therapy. The average age of men in the General group was (58.13 ± 10.13) [34–78] years, women — (61.33 ± 8.6) [42–81] years. The average duration of the disease in men (11.0 ± 8.15) years, in women — (12.35±8.94) years. HUE was diagnosed in 39.8 % (n = 64) of the examined patients. Patients with HUE along with standard hypoglycemic therapy were prescribed magnesium orotate: 1 week — 3 g per day, then 1.5 g per day for 3 months. Evaluation of the effectiveness of magnesium oroate therapy was carried out on the dynamics of the level of UA in the blood, glucose homeostasis, components of the blood lipid spectrum, heart rate and blood pressure. The data is analyzed using parametric statistics methods. It is shown that magnesium orotate therapy for 3 months in patients with type 2 diabetes with HUE, who receive oral hypoglycemic therapy, it contributes the level of UA in the blood, normalize the blood lipid spectrum and reduce the manifestations of insulin resistance; it leads to a decrease in heart rate and blood pressure, which significantly improves the clinical course of the disease and reduces the risk of developing chronic heart failure.